Chemotherapy options in castration-resistant prostate cancer

Conclusions: Chemotherapy remains an essential component of CRPC therapy, and biomarkers are being identified to define clinical scenarios where chemotherapy may be the optimal therapy choice.
Source: Indian Journal of Urology - Category: Urology & Nephrology Authors: Source Type: research